Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China flag China · Delayed Price · Currency is CNY
16.38
+0.25 (1.55%)
At close: Feb 13, 2026

SHE:300497 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
632.74695.35729.37978.031,2721,585
Trading Asset Securities
1.982.192.1949.74150.76106.68
Cash & Short-Term Investments
634.71697.54731.561,0281,4231,692
Cash Growth
-6.23%-4.65%-28.82%-27.79%-15.88%105.98%
Accounts Receivable
420.04498.16572.92552.49376.21314.38
Other Receivables
44.6953.85128.3178.2180.0157.44
Receivables
464.73552.01701.23630.71456.22371.82
Inventory
406.04421.05434.68553.69416.15287.98
Other Current Assets
18.8810.429.9717.1115.9714.98
Total Current Assets
1,5241,6811,8772,2292,3122,367
Property, Plant & Equipment
2,2812,2672,3312,2011,8571,199
Long-Term Investments
251.19255.9271.27271.42133.02153.78
Goodwill
---1.152.222.22
Other Intangible Assets
289.31235241.07249.71256.32246.28
Long-Term Deferred Tax Assets
31.137.2629.3728.4927.549.29
Long-Term Deferred Charges
-----2.2
Other Long-Term Assets
60.5560.9569.1378.7990.8266.71
Total Assets
4,4384,5374,8195,0604,6784,046
Accounts Payable
384.37603.37581.93656.67517.05418.6
Accrued Expenses
15.8244.0544.5242.451.9737.75
Short-Term Debt
631.39556.4549.83366.74615.18377.38
Current Portion of Long-Term Debt
260.9311.7878.787.9633.5-
Current Income Taxes Payable
10.690.050.828.7113.8942.11
Current Unearned Revenue
3.292.723.41.421.822.81
Other Current Liabilities
25.2525.4626.32174.96126.566.25
Total Current Liabilities
1,3321,5441,2861,2591,360884.9
Long-Term Debt
829.47736.48998.261,04335365
Long-Term Unearned Revenue
106.8977.6762.3962.0350.343.73
Long-Term Deferred Tax Liabilities
1.891.962.056.273.924.3
Total Liabilities
2,2702,3602,3482,3701,767997.93
Common Stock
538.65550550550550550
Additional Paid-In Capital
1,2471,3811,4141,4081,4061,465
Retained Earnings
346.03408.78680.88881.681,0231,084
Treasury Stock
--174.86-174.86-174.86-105.11-100.02
Comprehensive Income & Other
16.8215.4514.316.896.088.34
Total Common Equity
2,1492,1802,4852,6812,8803,007
Minority Interest
19.39-3.54-14.068.431.140.39
Shareholders' Equity
2,1682,1772,4712,6902,9113,048
Total Liabilities & Equity
4,4384,5374,8195,0604,6784,046
Total Debt
1,7221,6051,6271,4181,002442.38
Net Cash (Debt)
-1,087-907.13-895.31-389.97421.541,249
Net Cash Growth
-----66.26%957.75%
Net Cash Per Share
-2.02-1.70-1.65-0.720.782.70
Filing Date Shares Outstanding
538.65538.65538.65538.65538.65540.73
Total Common Shares Outstanding
538.65538.65538.65538.65543.13540.73
Working Capital
192.67137.2591.84970.42951.591,482
Book Value Per Share
3.994.054.614.985.305.56
Tangible Book Value
1,8591,9452,2442,4302,6222,759
Tangible Book Value Per Share
3.453.614.174.514.835.10
Buildings
-936.67836.72712.09471.86384.81
Machinery
-1,6411,4231,232851.39621.88
Construction In Progress
-457.86695.78736.4922.19494.37
Source: S&P Global Market Intelligence. Standard template. Financial Sources.